AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25433982 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4104
Study 25433982 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 4104
Study 23731042 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide anesthesia (with sevoflurane and a carrier gas of 40% O2 and 60% N2O)
Number of subjects: 81
Study 23731042 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide anesthesia
Number of subjects: 81
Study 23731042 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as patients without nitrous oxide)
Number of subjects: 81
Study 21950478 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention-oriented individuals with strong moral conviction
Number of subjects: 0
Study 21950478 — intervention group
Group type: COMPARATOR
Intervention: Promotion-oriented individuals
Number of subjects: 0
Study 19174434 — intervention group
Group type: EXPERIMENTAL
Intervention: Database studies using standard biostatistical methods
Number of subjects: 0
Study 19174434 — intervention group
Group type: EXPERIMENTAL
Intervention: Database studies using PERR analysis
Number of subjects: 0
Study 19174434 — intervention group
Group type: EXPERIMENTAL
Intervention: PERR adjusted hazard ratios
Number of subjects: 0
Study 22648373 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medication
Number of subjects: 1073
Study 22648373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1073
Study 22648373 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic cessation treatments
Number of subjects: 1073
Study 22648373 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation pharmacotherapy
Number of subjects: 1073
Study 15948725 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue glue (cyanoacrylate)
Number of subjects: 30
Study 15948725 — intervention group
Group type: COMPARATOR
Intervention: Suturing with interrupted 5/0 plain catgut
Number of subjects: 30
Study 12578928 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation 1
Number of subjects: 9
Study 12578928 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation 2
Number of subjects: 9
Study 12578928 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal response
Number of subjects: 9
Study 12578928 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral neuropathy
Number of subjects: 9
Study 12578928 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal subjects
Number of subjects: 9
Study 10539741 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily fish meal (3.65 g n‐3 fatty acids)
Number of subjects: 69
Study 10539741 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-loss regimen
Number of subjects: 69
Study 10539741 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish + weight-loss regimen
Number of subjects: 69
Study 10539741 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 8835567 — intervention group
Group type: EXPERIMENTAL
Intervention: biofeedback/relaxation
Number of subjects: 0
Study 8835567 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise
Number of subjects: 0
Study 8835567 — intervention group
Group type: EXPERIMENTAL
Intervention: combined program
Number of subjects: 0
Study 8835567 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 2140095 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (2 mg)
Number of subjects: 30
Study 2140095 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (0.5 mg)
Number of subjects: 30
Study 2140095 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (0.5 mg)
Number of subjects: 30
Study 530773 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 rpm pedalling rate
Number of subjects: 50
Study 530773 — intervention group
Group type: COMPARATOR
Intervention: 60 rpm pedalling rate
Number of subjects: 50
Study 530773 — intervention group
Group type: COMPARATOR
Intervention: 80 rpm pedalling rate
Number of subjects: 50
Study 11749097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (received feedback and advice)
Number of subjects: 264
Study 11749097 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 264
Study 11749097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 264
Study 31030805 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity board
Number of subjects: 133
Study 31030805 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 133
Study 29458267 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirmation task
Number of subjects: 273
Study 29458267 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 273
Study 27315831 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic SMS reminder repeating the RDT result and appropriate treatment actions
Number of subjects: 686
Study 27315831 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded SMS reminder stating that the 'government might allow pharmacists/chemists to do RDTs'
Number of subjects: 686
Study 27315831 — intervention group
Group type: COMPARATOR
Intervention: No SMS reminders (control)
Number of subjects: 686
Study 24510176 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray 200 μg once daily for 8 weeks
Number of subjects: 34
Study 24510176 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clarithromycin 500 mg twice daily for 2 weeks, then 250 mg once daily for 6 weeks, plus mometasone furoate
Number of subjects: 34
Study 24510176 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate nasal spray
Number of subjects: 34
Study 24510176 — intervention group
Group type: COMPARATOR
Intervention: Combined therapy (clarithromycin + mometasone)
Number of subjects: 34
Study 22473507 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided marking wire placement
Number of subjects: 184
Study 19834466 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LS)
Number of subjects: 30
Study 17917441 — intervention group
Group type: EXPERIMENTAL
Intervention: Previously developed norfloxacin tablet (M)
Number of subjects: 12
Study 17917441 — intervention group
Group type: EXPERIMENTAL
Intervention: Local norfloxacin tablet (L)
Number of subjects: 12
Study 17917441 — intervention group
Group type: COMPARATOR
Intervention: Multinational norfloxacin tablet (Noroxin)
Number of subjects: 12
Study 15842025 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a systematic care management program including initial assessment, monthly telephone monitoring, feedback to treatment team, and structured group psychoeducational program provided by a nurse care manager.
Number of subjects: 441
Study 15842025 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 441
Study 12197593 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol group (intravenous esmolol drip during CPB to maintain heart rate at 30‐50 beats/min)
Number of subjects: 24
Study 12197593 — intervention group
Group type: COMPARATOR
Intervention: Control group (normothermia CPB direct version intracardiac beating heart surgery)
Number of subjects: 24
Study 10456626 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventak AV
Number of subjects: 33
Study 10456626 — intervention group
Group type: COMPARATOR
Intervention: Ventak Mini
Number of subjects: 33
Study 7792497 — intervention group
Group type: EXPERIMENTAL
Intervention: flurazepam 30 mg
Number of subjects: 15
Study 7792497 — intervention group
Group type: EXPERIMENTAL
Intervention: zolpidem 10 mg
Number of subjects: 15
Study 7792497 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 2358973 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice (AJ) feeding
Number of subjects: 49
Study 2358973 — intervention group
Group type: COMPARATOR
Intervention: Formula feeding
Number of subjects: 49
Study 41546 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 30 mg
Number of subjects: 75
Study 41546 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutethimide 500 mg
Number of subjects: 75
Study 41546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 29705216 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive endotracheal tube suctioning (MIETS)
Number of subjects: 64
Study 29705216 — intervention group
Group type: COMPARATOR
Intervention: Routine endotracheal tube suctioning (RETS)
Number of subjects: 64
Study 27751729 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line everolimus
Number of subjects: 471
Study 27751729 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line sunitinib
Number of subjects: 471
Study 25673981 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg once daily
Number of subjects: 70
Study 25673981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 22647521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OXT)
Number of subjects: 15
Study 22647521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 21334433 — intervention group
Group type: EXPERIMENTAL
Intervention: AKI patients
Number of subjects: 20
Study 18937094 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric assessment tool on personal digital assistant
Number of subjects: 72
Study 18937094 — intervention group
Group type: COMPARATOR
Intervention: No geriatric assessment tool on personal digital assistant
Number of subjects: 72
Study 16377449 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily IVR reporting with personal follow-up on noncompliant callers
Number of subjects: 60
Study 16377449 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily IVR reporting without follow-up
Number of subjects: 60
Study 16377449 — intervention group
Group type: COMPARATOR
Intervention: No IVR reporting (control group)
Number of subjects: 60
Study 14529670 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC 6), followed by paclitaxel (175 mg/m(2) over 3 h) (C-P)
Number of subjects: 40
Study 14529670 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel (175 mg/m(2) over 3 h), followed by carboplatin (AUC 6) (P-C)
Number of subjects: 40
Study 10923634 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose infusion (6 mg/kg over 1 min every 10 min)
Number of subjects: 20
Study 10923634 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 20
Study 10923634 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated glucose infusion rate in diabetic subjects
Number of subjects: 20
Study 8753109 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (50 microns/m2, subcutaneously) administered when leukocyte count is ≤ 1000/mm3
Number of subjects: 66
Study 8753109 — intervention group
Group type: COMPARATOR
Intervention: G-CSF (50 microns/m2, subcutaneously) administered when leukocyte count is between 1000/mm3 and 2000/mm3
Number of subjects: 66
Study 1864255 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram/Lithium
Number of subjects: 14
Study 1864255 — intervention group
Group type: COMPARATOR
Intervention: Citalopram/Placebo
Number of subjects: 14
Study 6612689 — intervention group
Group type: EXPERIMENTAL
Intervention: High saturated fat diet (P/S ratio 1:8)
Number of subjects: 55
Study 6612689 — intervention group
Group type: EXPERIMENTAL
Intervention: High polyunsaturated fat diet (P/S ratio 4:1)
Number of subjects: 55
Study 6612689 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol (20 gm/day)
Number of subjects: 55
Study 6612689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 30596338 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint interval training (5 to 6, 30 second 'all out' running sprints, 3 times per week for 4 weeks)
Number of subjects: 56
Study 30596338 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint interval training
Number of subjects: 56
Study 30596338 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal physical education lessons)
Number of subjects: 56
Study 28283732 — intervention group
Group type: EXPERIMENTAL
Intervention: half-dose photodynamic therapy (hd-PDT)
Number of subjects: 40
Study 28283732 — intervention group
Group type: COMPARATOR
Intervention: 689 nm laser therapy (689-LT)
Number of subjects: 40
Study 25308628 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance exercise
Number of subjects: 19
Study 25308628 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise
Number of subjects: 19
Study 25308628 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training added to both groups after 3 months
Number of subjects: 19
Study 23871475 — intervention group
Group type: EXPERIMENTAL
Intervention: HF disease management program (HF-DMP)
Number of subjects: 12
Study 21307009 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 µg kg(‐1) i.v. over 20 min followed by 0.7 µg kg(‐1) h(‐1) infusion for 190 min)
Number of subjects: 12
Study 21307009 — intervention group
Group type: COMPARATOR
Intervention: Morphine hydrochloride (0.10 mg kg(‐1) i.v. over 20 min)
Number of subjects: 12
Study 21307009 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study 19194156 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (2.0 mg/kg)
Number of subjects: 84
Study 19194156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 16401664 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 100 mg
Number of subjects: 12
Study 16401664 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 1.5 mg
Number of subjects: 12
Study 16401664 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (50, 75, and 100 mg)
Number of subjects: 12
Study 16401664 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam 0.5 mg
Number of subjects: 12
Study 15340535 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b 3MU added to ongoing lamivudine, daily for one month, then every other day for five months
Number of subjects: 40
Study 15340535 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable oxymatrine 60 mg daily for three months, followed by oral oxymatrine every day for three months
Number of subjects: 40
Study 15340535 — intervention group
Group type: COMPARATOR
Intervention: Ongoing treatment with lamivudine alone
Number of subjects: 40
Study 10931126 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable domestic dehumidifier
Number of subjects: 76
Study 10931126 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural programme
Number of subjects: 76
Study 10931126 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 76
Study 9924298 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐DTPA gel
Number of subjects: 12
Study 9924298 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐carbon gel
Number of subjects: 12
Study 9924298 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 12
Study 7752839 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard gelatin capsule containing 100 mg of CoQ and 400 mg of Emcompress
Number of subjects: 10
Study 7752839 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft gelatin capsule containing 100 mg of CoQ with 400 mg of soy bean oil (Bioquinon)
Number of subjects: 10
Study 7752839 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft gelatin capsule containing 100 mg of CoQ with 20 mg of polysorbate 80, 100 mg of lecithin and 280 mg of soy bean oil
Number of subjects: 10
Study 7752839 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft gelatin capsule containing 100 mg of CoQ with 20 mg of polysorbate 80 and 380 mg of soy bean oil
Number of subjects: 10
Study 3287813 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of 100 mg indomethacin
Number of subjects: 0
Study 3287813 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of 50 mg indomethacin
Number of subjects: 0
Study 31161926 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Imagery (GI)
Number of subjects: 0
Study 31161926 — intervention group
Group type: COMPARATOR
Intervention: Audiobook (AB) placebo treatment
Number of subjects: 0
Study 29568743 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physical activity program (12 weeks, 24 exercise sessions)
Number of subjects: 50
Study 29568743 — intervention group
Group type: COMPARATOR
Intervention: Regular physical activity (control group)
Number of subjects: 50
Study 24841502 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted epidural steroid injections
Number of subjects: 112
Study 24841502 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic-guided epidural steroid injections
Number of subjects: 112
Study 24446548 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram treatment for 8 weeks
Number of subjects: 17
Study 24446548 — intervention group
Group type: EXPERIMENTAL
Intervention: BOLD responses to negative words
Number of subjects: 17
Study 24446548 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximally predictive clusters of voxels
Number of subjects: 17
Study 21641002 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy expenditure exercise (16 kcal/kg/week)
Number of subjects: 104
Study 21641002 — intervention group
Group type: COMPARATOR
Intervention: Low energy expenditure exercise (4 kcal/kg/week)
Number of subjects: 104
Study 18219479 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilisate
Number of subjects: 44
Study 18219479 — intervention group
Group type: COMPARATOR
Intervention: Eye drops
Number of subjects: 44
Study 16579998 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurements of serum insulin, leptin, sOB-R at fasting and during a standard oral glucose tolerance test (OGTT)
Number of subjects: 55
Study 12061352 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen-arginine (1 drop/kg: 6.67 mg/kg)
Number of subjects: 100
Study 12061352 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (4 drops/kg: 10.65 mg/kg)
Number of subjects: 100
Study 12061352 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen-arginine
Number of subjects: 100
Study 12061352 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 100
Study 10023515 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% CO2 challenge
Number of subjects: 31
Study 10023515 — intervention group
Group type: COMPARATOR
Intervention: Control group (14 relatives free from psychiatric diagnoses)
Number of subjects: 31
Study 7771617 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg LMWH (enoxaparin) once daily
Number of subjects: 1427
Study 7771617 — intervention group
Group type: COMPARATOR
Intervention: 5,000 IU SH TID
Number of subjects: 1427
Study 2313607 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-insulin-dependent diabetes (diet, tablet, or ultralente insulin therapy)
Number of subjects: 178
Study 2313607 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetes
Number of subjects: 178
Study 379049 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide mouthwash (Amosan), 1.7 g powder dissolved in 30 ml hot tap water, rinsed after meals for 2 weeks
Number of subjects: 14
Study 379049 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash, rinsed after meals for 2 weeks
Number of subjects: 14
Study 6342565 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline hydrochloride alone, up to a maximum dosage of 300 mg/day
Number of subjects: 60
Study 6342565 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranylcypromine alone, up to 40 mg/day
Number of subjects: 60
Study 6342565 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amitriptyline hydrochloride, up to 150 mg/day, and tranylcypromine, up to 20 mg/day
Number of subjects: 60
Study 30875753 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical and oropharyngeal exercise program, including an eight-week urban-walking program, oropharyngeal exercises, and diet and sleep recommendations.
Number of subjects: 27
Study 30875753 — intervention group
Group type: COMPARATOR
Intervention: Control group followed diet and sleep recommendations only.
Number of subjects: 27
Study 30875753 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive multimodal program (including exercise, diet, and sleep recommendations).
Number of subjects: 27
Study 29766636 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin/Linagliptin 10/5
Number of subjects: 433
Study 29766636 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Linagliptin 10/5
Number of subjects: 433
Study 27534081 — intervention group
Group type: EXPERIMENTAL
Intervention: TKA with individual osteotomy instrument
Number of subjects: 40
Study 27534081 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 40
Study 25056511 — intervention group
Group type: EXPERIMENTAL
Intervention: Vericiguat (BAY 1021189) - once-daily oral sGC stimulator over 12 weeks
Number of subjects: 0
Study 25056511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22252107 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-skimmed milk (950 kJ)
Number of subjects: 24
Study 22252107 — intervention group
Group type: COMPARATOR
Intervention: Regular cola (900 kJ)
Number of subjects: 24
Study 22252107 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-containing drinks (SSSD and semi-skimmed milk)
Number of subjects: 24
Study 22252107 — intervention group
Group type: COMPARATOR
Intervention: Aspartame-sweetened soft drink (ASSD)
Number of subjects: 24
Study 22252107 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 24
Study 20810589 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SHA-CMHA services
Number of subjects: 505
Study 20810589 — intervention group
Group type: COMPARATOR
Intervention: CMHA services alone
Number of subjects: 505
Study 17997772 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide injections (0.2 mL of 10 mg/mL)
Number of subjects: 136
Study 17997772 — intervention group
Group type: EXPERIMENTAL
Intervention: Incision and curettage
Number of subjects: 136
Study 17997772 — intervention group
Group type: COMPARATOR
Intervention: Hot compresses (conservative treatment)
Number of subjects: 136
Study 16329018 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 0.5 mg/kg intravenously (group 1)
Number of subjects: 44